Publication

2023

Journal

• "Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy"
  Bhatia, V.; Kamat, N. V.; Pariva, T. E.; Wu, L.-T.; Tsao, A.; Sasaki, K.; Sun, H.; Javier, G.; Nutt, S.; Coleman, I.; Hitchcock, L.; Zhang, A.; Rudoy, D.; Gulati, R.; Patel, R. A.; Roudier, M. P.; True, L. D.; Srivastava, S.; Morrissey, C. M.; Haffner, M. C.; Nelson, P. S.; Priceman, S. J.; Ishihara, J.; Lee, J. K
  Nature communications 14 (1), 2041 (2023).

  • DOI: https://doi.org/10.21417/VB2023NC
• "Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting"
  Lee EHJ., Cullen C, Murad JP, Gumber D, Park AK, Yang J, Stern LA, Adkins LN, Dhapola G, Gittins B, Chang W, Ishihara J, Lee JL, Forman SJ, Wang LD, Priceman SJ.
  Nature communications (2023).
• "Topically-Applied Collagen-Binding Serum Albumin-Fused Interleukin-4 Potentiates Wound Healing in a Type 2 Diabetic Mouse Model "
  Lauterbach AL, Wallace RP, Alpar AT, Refvik KC, Ako Ishihara, Beckman TN, Slezak AJ, Mansurov A, Gomes S, Ishihara J#, Hubbell JA #
  NPJ regenerative medicine (2023).
• "The Clinical Terrain of Immunotherapies in Heterogeneous Pancreatic Cancer: Unravelling Challenges and Opportunities"
  Herpels M, Ishihara J, Sadanandam A
  Journal of pathology (2023).
• "Capillary-Scale Hydrogel Microchannel Networks by Wire Templating "
  Kawara S, Cunningham B, Bezer J, Neelima KC,1 Jingwen Zhu,1 Meng-Xing Tang, Ishihara J, Choi JJ, Au S
  Small (2023).
• "An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2"
  Aliyah B Silver , Stephany Y Tzeng , Mallory Lager , Jeremy Wang, Jun Ishihara, Jordan J Green, Jamie B Spangler
  Cell Rep Med Nov 21;4(11):101289 (2023).

  • DOI: 10.1016/j.xcrm.2023.101289